Biotechnology--InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced a strategic research ...
Greenbrier’s Q4 results outpaced Wall Street expectations for both revenue and earnings, even as sales declined nearly 20% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback